Professor Tracey O’Brien and the Hon Jillian Skinner have been appointed a Member of the Order of Australia (AM) – Cancer Institute NSW
“We are proud to share Professor Tracey O’Brien and the Hon Jillian Skinner have been appointed a Member of the Order of Australia (AM) – recognised for careers dedicated to improving health across NSW and beyond.
Professor O’Brien AM, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, has been at the forefront of cancer care, research and innovation nationally and internationally for more than 25 years.
The Hon Jillian Skinner, Cancer Institute NSW board member, served NSW in parliament for 23 years, including six as NSW Minister for Health and 14 as Shadow Health Minister.
Please join us in congratulating Professor Tracey O’Brien AM and the Hon Jillian Skinner AM.
Hear from them both and find out more about their work.”
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program.
Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group.
In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology.
In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University).
Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.